Build your Products with Quality through our Agile Bioequivalence (BE) and Bioavailability (BA) Services

What Sets Us Apart!

Bioavailability (BA) and Bioequivalence (BE) studies are performed for developing a new formulation or for marketing a generic drug. If you wish to register your drug in the international market(s) especially in stringent regulatory markets, BA/BE studies are part of the requirements for authorities like EU GMP, MHRA, JFDA & USFDA. The right choice of a Clinical Research Organization is vital for a successful market launch.

DRK is one of the Leading global Clinical Research Organizations (CRO) with Qualified Partners and Affiliate facilities in Australia, Jordan, India, US and Canada with experience spanning over a decade of services to the generics and biosimilar industries.

Our Services

DRK in alliance with Biocentres across the world offers the following services for BA/BE studies including:

• Bio-Analytical Services
• Quality Assurance Services
• Expert Reports
• Medical Lab Services
• Data Management Services
• Clinical Services
• Clinical Monitoring Services